0002067687-25-000011.txt : 20250714 0002067687-25-000011.hdr.sgml : 20250714 20250714135101 ACCESSION NUMBER: 0002067687-25-000011 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20250714 DATE AS OF CHANGE: 20250714 EFFECTIVENESS DATE: 20250714 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IEQ Capital Access Fund - Abingworth Clinical Co-Development 3, L.P. CENTRAL INDEX KEY: 0002071562 ORGANIZATION NAME: EIN: 335068804 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-551618 FILM NUMBER: 251121113 BUSINESS ADDRESS: STREET 1: C/O COMPLIANCE DEPARTMENT STREET 2: 60 EAST 42ND STREET, 28TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10165 BUSINESS PHONE: 2129947400 MAIL ADDRESS: STREET 1: C/O COMPLIANCE DEPARTMENT STREET 2: 60 EAST 42ND STREET, 28TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10165 D 1 primary_doc.xml X0708 D LIVE 0002071562 IEQ Capital Access Fund - Abingworth Clinical Co-Development 3, L.P. C/O COMPLIANCE DEPARTMENT 60 EAST 42ND STREET, 28TH FLOOR NEW YORK NY NEW YORK 10165 2129947400 DELAWARE None None Limited Partnership true 2025 - iCapital PE GP, LLC c/o Compliance Department 60 East 42nd Street, 28th Floor New York NY NEW YORK 10165 Promoter General Partner of the Issuer Michael Stanton c/o Compliance Department New York NY NEW YORK 10165 Executive Officer Authorized Signatory of the General Partner of the Issuer Pooled Investment Fund Private Equity Fund false Decline to Disclose 06c 3C 3C.7 false true false true true false 0 Indefinite 0 Indefinite false 0 0 0 0 false IEQ Capital Access Fund - Abingworth Clinical Co-Development 3, L.P. Michael Stanton Michael Stanton Authorized Signatory of the General Partner of the Issuer 2025-07-10